Anteris Technologies Global Inc (AVR)
Anteris Technologies Global Inc is a healthcare company listed on the NASDAQ under the ticker AVR. The company focuses on structural heart therapies and develops minimally invasive medical devices for the treatment of heart valve disease. Its product portfolio includes the DurAVR transcatheter heart valve system, designed for patients with severe aortic stenosis, as well as the ADAPT anti-calcification tissue platform, which is used to create durable bioscaffolds for surgical repair applications, including aortic valve replacement. Anteris also develops the ComASUR delivery system, a balloon-expandable platform with a reinforced steerable catheter intended to support controlled navigation through heart anatomy. The company is based in Toowong, Australia.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-AVR
|
$7.18
|
-11.2% Downside
|
Fair
|
$15.33
|
89.8% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 17, 2026
|
-8.2x
|
2.8x
|
423.3x
|
801.1 M
|
504.5 M
|
0.5%
|
62.0%
|
20.7
|
—
|
91.1%
|
